Search Results 651-660 of 9101 for albumin

  1. Intestinal Cancer Clinical Trials - Mayo Clinic Research

    Ramucirumab is a monoclonal antibody that attaches to and inhibits a molecule called VEGFR-2. This may restrain new blood vessel formation therefore reducing ...

  2. A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Management of Anal Fistulas - Mayo Clinic

    ... Albumin (HSA); Dulbecco Modified Eagle's Medium (DMEM); materials of bovine origin; local anaesthetics or gadolinium (MRI contrast); Known hypersensitivity ...

  3. Overview - Mayo Clinic

    Macroglobulinemia; Monoclonal gammopathy-associated conditions including C1-esterase inhibitor deficiency, cryoglobulinemia, osteosclerotic myeloma, peripheral ...

  4. Phase 1 Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Splicing Modulator H3B-8800 for Subjects With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia - Mayo Clinic

    Albumin ≥ 2.5 mg/dL. Willing and able to comply with all aspects of the protocol. Provide written informed consent prior to any study-specific Screening ...

  5. A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers - Mayo Clinic

    History of severe infusion reaction to monoclonal antibodies or biological therapies, or to study product excipients (e.g., human serum albumin, dimethyl ...

  6. A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors - Mayo Clinic

    Albumin < 2.8 g/dL 5. ECG Exclusion a. Screening QTc interval > 450 milliseconds for males and QTc > 470 ms for females (corrected by Fridericia) 6. Other ...

  7. Hematology - Clinical trials

    Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.

  8. Consumer health Medications - Mayo Clinic

    Could it affect other treatments I take? Make sure to tell your doctor if you take any herbs, supplements or medicines, whether or not they need a prescription.

  9. Paired Marrow Aspirations to Assess Assays in Sensitized Renal Allograft Recipients - Mayo Clinic

    The aim of this study is to determine the validity of two tests on bone marrow of sensitized kidney transplant recipients in order to better understand why ...

  10. A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers - Mayo Clinic

    - Albumin >= 3.0 g/dL - Prothrombin time (PT)/activated partial thromboplastin time (aPTT) =< 1.5 x ULN (This applies only to patients who do not receive ...